ICH Considerations: oncolytic viruses

  • Email
  • Help
Current version

ICH Considerations

Reference numberEMEA/CHMP/ICH/607698/2008
KeywordsGene therapy, oncolytic viruses, wild type, genetically modified oncolytic viruses, manufacture, characterisation, non-clinical, clinical, biosafety
DescriptionThis document describes the general principles for the manufacturing, characterisation, non-clinical and clinical testing of medicinal products based on oncolytic viruses.

Related content

How helpful is this page?

Average rating:

 Based on 20 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
4 ratings

Tell us more